Loading viewer...
earnings
Format: PDF earnings
Novartis presents Q2 2024 financial results and company overview as of July 18, 2024. The presentation covers financial review, strategic initiatives including the MorphoSys acquisition, and Novartis's transformation into a pure-play innovative medicines company following the Sandoz spin-off.
brochure
earnings
17 Pages
OnMobile Global Limited
Palo Alto Networks Q3 FY2024 Earnings Call May 2024
earningsearnings
30 Pages
Palo Alto Networks, Inc.
MDU Resources Q1 2023 Earnings Call Presentation
earningsearnings
21 Pages
MDU Resources Group, Inc.
Independent Bank Group Q3 2016 Earnings Presentation
earningsearnings
17 Pages
Independent Bank Group, Inc.
IBERIABANK Q2 2016 Earnings Presentation
earningsearnings
54 Pages
IberiaBank Corporation
